EXPO vs. FCN, DNB, CBZ, VSEC, HURN, ICFI, CRAI, ACTG, FC, and MG
Should you be buying Exponent stock or one of its competitors? The main competitors of Exponent include FTI Consulting (FCN), Dun & Bradstreet (DNB), CBIZ (CBZ), VSE (VSEC), Huron Consulting Group (HURN), ICF International (ICFI), Charles River Associates (CRAI), Acacia Research (ACTG), Franklin Covey (FC), and Mistras Group (MG). These companies are all part of the "research & consulting services" industry.
Exponent vs. Its Competitors
Exponent (NASDAQ:EXPO) and FTI Consulting (NYSE:FCN) are both mid-cap business services companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, media sentiment, dividends, profitability, valuation and risk.
In the previous week, FTI Consulting had 9 more articles in the media than Exponent. MarketBeat recorded 14 mentions for FTI Consulting and 5 mentions for Exponent. FTI Consulting's average media sentiment score of 0.70 beat Exponent's score of 0.46 indicating that FTI Consulting is being referred to more favorably in the news media.
92.4% of Exponent shares are held by institutional investors. Comparatively, 99.4% of FTI Consulting shares are held by institutional investors. 1.6% of Exponent shares are held by insiders. Comparatively, 1.8% of FTI Consulting shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
FTI Consulting has higher revenue and earnings than Exponent. FTI Consulting is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.
Exponent has a beta of 0.92, suggesting that its stock price is 8% less volatile than the S&P 500. Comparatively, FTI Consulting has a beta of 0.19, suggesting that its stock price is 81% less volatile than the S&P 500.
Exponent currently has a consensus target price of $120.00, indicating a potential upside of 60.62%. FTI Consulting has a consensus target price of $175.50, indicating a potential upside of 8.61%. Given Exponent's stronger consensus rating and higher possible upside, equities analysts plainly believe Exponent is more favorable than FTI Consulting.
Exponent has a net margin of 18.87% compared to FTI Consulting's net margin of 7.14%. Exponent's return on equity of 25.33% beat FTI Consulting's return on equity.
Summary
Exponent beats FTI Consulting on 8 of the 15 factors compared between the two stocks.
Get Exponent News Delivered to You Automatically
Sign up to receive the latest news and ratings for EXPO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding EXPO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Exponent Competitors List
Related Companies and Tools
This page (NASDAQ:EXPO) was last updated on 7/1/2025 by MarketBeat.com Staff
Free EXPO Stock Alerts